Skip to content

News archive

Julia Wigren Byström, CEO of Xerum.

Xerum assigned by Swedish Public Health Agency to measure number of Swedes with antibodies against SARS-CoV-2

Umeå-based Xerum launched a home testing kit in March that detects antibodies against SARS-CoV-2 - the virus that causes Covid-19. Uptake of the kits was strong, and now the company has been given an important assignment by the Swedish Public Health Agency. “We will be responsible for the distribution and analysis of our self-sampling kits as part of a large study” says Julia Wigren Byström, CEO.

Lipum.

Lipum raises SEK 85 million and become listed on Nasdaq First North

Umeå-based biopharmaceutical company Lipum has been working towards a stock exchange listing since 2018 – and now the moment has finally arrived. On Thursday, April 22, shares in Lipum will be traded on the Nasdaq First North Growth Market for the very first time. The company will ring Nasdaq's opening bell, which has been specially transported to Umeå, to mark the occasion.

New at QureTech Bio: Annica Rönnbäck, Mari Bonde and Souvik Sarkar.

QureTech Bio expands workforce following major investment

Umeå-based pharmaceutical development company QureTech Bio is hiring more people as it intensifies its work to combat antibiotic resistance. “We recently received a major investment which has created long-term security in the company. With more people in place, we can now really push on and look to the future”, says Helén Fält, who was recently appointed the new CEO of QureTech Bio.

Umeå Biotech Incubator

Umeå Biotech Incubator named Europe's most innovative biotechnology incubator

Global Health and Pharma Magazine has named Umeå Biotech Incubator (UBI) as Europe's most innovative biotechnology incubator in recognition of the positive changes it is making to the biotech industry.
“We are delighted to have been given this award, and that word of our innovative way of working has spread from Umeå to the whole of Europe. It's really cool”, says Jennie Ekbeck, CEO of Umeå Bio

Stefan K Nilsson, CEO of Lipigon.

Lipigon share issue oversubscribed ahead of March stock market launch

A new share issue in Umeå-based Lipigon Pharmaceuticals that was issued ahead of a listing on the Nasdaq First North Growth Market has exceeded all expectations. The listing was oversubscribed by 479 per cent, raising SEK 235 million spread over more than 9,000 investors.

Helén Fält and Fredrik Almqvist, QureTech Bio.

QureTech Bio Looks to the Future With Appointment of New CEO

Umeå-based biotech company QureTech Bio has appointed Helén Fält as its new acting CEO, replacing Fredrik Almqvist, one of the company’s original founders. “We have recently secured significant new investment and so it feels like the perfect time for Helén to come in and develop our business even further,” says Fredrik Almqvist.

Urban Paulsson and Stefan K Nilsson, CEO of Lipigon.

Urban Paulsson new Chairman of the Board of Lipigon Pharmaceuticals

Lipigon Pharmaceuticals AB, which develops new treatments for lipid-related diseases, announces that the board has elected Urban Paulsson as the new chairman of the board. Paulsson was elected to the board on October 30, 2020 and now replaces Carina Schmidt, who requested her own resignation from the board.

Show more

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden